Premier partner for high-quality biosimilar monoclonal antibodies for unmet need indications such as cancer, inflammation and autoimmunity, including adaptive immunity.
Target indication for new antibody therapeutics also include cardiovascular diseases, inflammatory diseases such as asthma, and the very effective new immune-oncology drugs
Primary Therapeutic Areas
1.0 Therapeutic & Diagnostic
1.00 Antibodies & Anti-infectious
1.2 R&D Services
1.27 Drug Discovery & Delivery
1.33 Synthesis Services